Vita Life Sciences Limited provided earnings guidance for the half year ending 30 June 2023. For the period, the company expects Sales: $33.0 million to $33.5 million (H1 2022: $32.7 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 AUD | -0.48% | -6.31% | +16.85% |
1st Jan change | Capi. | |
---|---|---|
+16.85% | 76.97M | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- VLS Stock
- News Vita Life Sciences Limited
- Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending 30 June 2023